Results 181 to 190 of about 54,960 (249)

Navigating care: understanding cancer patients' experiences with systemic radionuclide therapy. [PDF]

Support Care Cancer
Starkbaum J, Thircuir S, Winkler F, Griessler E.   +3 more
europepmc   +1 more source

Optimizing uPAR-targeting radiopeptides for improved tissue distribution: progress towards radionuclide therapy. [PDF]

Eur J Nucl Med Mol Imaging
Vaccarin C, Beyer D, Schmid JV, Klein B, Jegathasan J, Behera S, Deupi X, Schibli R, Müller C.   +8 more
europepmc   +1 more source

Outcome and safety of single-dose docetaxel-augmented targeted radionuclide therapy using [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy in treatment-refractory mCRPC: preliminary evidence from a pilot experience. [PDF]

EJNMMI Res
Ebert N, Rosar F, Burgard C, Bartholomä M, Maus S, Hein C, Blickle A, Ezziddin S, Khreish F.   +8 more
europepmc   +1 more source

Development of a Novel Engineered Antibody Format for PSMA-Targeted Radionuclide Therapy. [PDF]

Mol Pharm
Fletcher NL, Houston ZH, Chandler PG, Yan E, Holgate R, Wheatcroft M, Thurecht KJ.   +6 more
europepmc   +1 more source

Editorial: Women in radionuclide therapy: 2023

Frontiers in Nuclear Medicine
Egesta Lopci, Federica Matteucci
doaj   +1 more source

Machine Learning Uncovers Novel Predictors of Peptide Receptor Radionuclide Therapy Eligibility in Neuroendocrine Neoplasms. [PDF]

Cancers (Basel)
Sipka G, Farkas I, Bakos A, Maráz A, Mikó ZS, Czékus T, Bukva M, Urbán S, Pávics L, Besenyi Z.   +9 more
europepmc   +1 more source

Peptide receptor radionuclide therapy alone or in combination with temozolomide plus/minus capecitabine in [¹⁸F]FDG-positive metastatic neuroendocrine tumors. [PDF]

Eur J Nucl Med Mol Imaging
di Santo G, Santo G, Wirth L, Kronthaler A, Gastl G, Djanani A, Virgolini IJ.   +6 more
europepmc   +1 more source

On the reduction of imaging time-points for dosimetry in radionuclide therapy. [PDF]

EJNMMI Phys
Gustafsson J, Taprogge J.
europepmc   +1 more source

Recommendations for reporting preclinical radiobiological studies in targeted radionuclide therapy. [PDF]

Eur J Nucl Med Mol Imaging
Mendes F, Terry SYA, Spiegelberg D, Cornelissen B, Bolcaen J, Nonnekens J, European Working group of Radiobiology of Molecular Radionuclide Therapy.   +6 more
europepmc   +1 more source

Enhanced Radionuclide Therapy via the Conjugation of Pentadecanoic Acids With ²²⁵Ac- and ¹⁷⁷Lu-Labeled RGD Peptides. [PDF]

Cancer Sci
Yoshimoto M, Wada SI, Yoshii Y, Hanadate S, Inaki A, Fujii H.   +5 more
europepmc   +1 more source